248 related articles for article (PubMed ID: 17021762)
41. In vivo reflectance confocal microscopy of mycosis fungoides: A preliminary study.
Agero AL; Gill M; Ardigo M; Myskowski P; Halpern AC; González S
J Am Acad Dermatol; 2007 Sep; 57(3):435-41. PubMed ID: 17433849
[TBL] [Abstract][Full Text] [Related]
42. [Analysis of cloning rearrangement of T-cell receptor gamma gene in primary cutaneous lymphoma].
Pawlaczyk M; Kistowska M; Poreba E; Filas V; Breborowicz J; Goździcka-Józefiak A
Pol Merkur Lekarski; 2003 Nov; 15(89):420-3. PubMed ID: 14969134
[TBL] [Abstract][Full Text] [Related]
43. Efficacy of treatments for mycosis fungoides and Sézary syndrome: nationwide survey responses.
Gettler SL; Fung MA
Dermatol Online J; 2005 Dec; 11(3):6. PubMed ID: 16409902
[TBL] [Abstract][Full Text] [Related]
44. EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome.
Trautinger F; Knobler R; Willemze R; Peris K; Stadler R; Laroche L; D'Incan M; Ranki A; Pimpinelli N; Ortiz-Romero P; Dummer R; Estrach T; Whittaker S
Eur J Cancer; 2006 May; 42(8):1014-30. PubMed ID: 16574401
[TBL] [Abstract][Full Text] [Related]
45. Simplified flow cytometric assessment in mycosis fungoides and Sézary syndrome.
Hristov AC; Vonderheid EC; Borowitz MJ
Am J Clin Pathol; 2011 Dec; 136(6):944-53. PubMed ID: 22095381
[TBL] [Abstract][Full Text] [Related]
46. Fli-1 expression in mycosis fungoides.
Quick CM; Smoller BR; Hiatt KM
J Cutan Pathol; 2006 Sep; 33(9):642-5. PubMed ID: 16965340
[TBL] [Abstract][Full Text] [Related]
47. Mycosis fungoides and Sézary syndrome tumor cells express epidermal fatty acid-binding protein, whose expression decreases with loss of epidermotropism.
Takahashi-Shishido N; Sugaya M; Morimura S; Suga H; Oka T; Kamijo H; Miyagaki T; Sato S
J Dermatol; 2021 May; 48(5):685-689. PubMed ID: 33560534
[TBL] [Abstract][Full Text] [Related]
48. Heterogeneity of T-cell receptor expression at transformation in mycosis fungoides/Sezary Syndrome (MF/SS).
Jothishankar B; Venkataraman G; Goldberg RC; Abdulla F
Ann Diagn Pathol; 2019 Dec; 43():151404. PubMed ID: 31629155
[No Abstract] [Full Text] [Related]
49. Cytologic evaluation of lymphadenopathy associated with mycosis fungoides and Sezary syndrome: role of immunophenotypic and molecular ancillary studies.
Pai RK; Mullins FM; Kim YH; Kong CS
Cancer; 2008 Oct; 114(5):323-32. PubMed ID: 18798522
[TBL] [Abstract][Full Text] [Related]
50. Comparative analysis of histological and immunohistological features in mycosis fungoides and Sézary syndrome.
Kamarashev J; Burg G; Kempf W; Hess Schmid M; Dummer R
J Cutan Pathol; 1998 Sep; 25(8):407-12. PubMed ID: 9826165
[TBL] [Abstract][Full Text] [Related]
51. Absence of CD26 expression is a useful marker for diagnosis of T-cell lymphoma in peripheral blood.
Jones D; Dang NH; Duvic M; Washington LT; Huh YO
Am J Clin Pathol; 2001 Jun; 115(6):885-92. PubMed ID: 11392886
[TBL] [Abstract][Full Text] [Related]
52. CD147-Cyclophilin a Interactions Promote Proliferation and Survival of Cutaneous T-Cell Lymphoma.
Sakamoto M; Miyagaki T; Kamijo H; Oka T; Boki H; Takahashi-Shishido N; Suga H; Sugaya M; Sato S
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360654
[TBL] [Abstract][Full Text] [Related]
53. Elevated gene expression of Th1/Th2 associated transcription factors is correlated with disease activity in patients with systemic lupus erythematosus.
Lit LC; Wong CK; Li EK; Tam LS; Lam CW; Lo YM
J Rheumatol; 2007 Jan; 34(1):89-96. PubMed ID: 17117487
[TBL] [Abstract][Full Text] [Related]
54. Roles of OX40 and OX40 Ligand in Mycosis Fungoides and Sézary Syndrome.
Kawana Y; Suga H; Kamijo H; Miyagaki T; Sugaya M; Sato S
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830466
[TBL] [Abstract][Full Text] [Related]
55. Microscopic study of normal skin in cases of mycosis fungoides.
El-Darouti MA; Marzouk SA; Bosseila M; Zeid OA; El-Safouri O; Zayed A; El-Ramly A; Abdel-Halim MR
Int J Dermatol; 2006 Sep; 45(9):1043-6. PubMed ID: 16961506
[TBL] [Abstract][Full Text] [Related]
56. Prevalence and treatment of Staphylococcus aureus colonization in patients with mycosis fungoides and Sézary syndrome.
Talpur R; Bassett R; Duvic M
Br J Dermatol; 2008 Jul; 159(1):105-12. PubMed ID: 18489588
[TBL] [Abstract][Full Text] [Related]
57. A patient with clinicopathologic features of small plaque parapsoriasis presenting later with plaque-stage mycosis fungoides: report of a case and comparative retrospective study of 27 cases of "nonprogressive" small plaque parapsoriasis.
Belousova IE; Vanecek T; Samtsov AV; Michal M; Kazakov DV
J Am Acad Dermatol; 2008 Sep; 59(3):474-82. PubMed ID: 18694680
[TBL] [Abstract][Full Text] [Related]
58. A distinct profile of serum levels of soluble intercellular adhesion molecule-1 and intercellular adhesion molecule-3 in mycosis fungoides and Sézary syndrome.
López-Lerma I; Estrach MT
J Am Acad Dermatol; 2009 Aug; 61(2):263-70. PubMed ID: 19615537
[TBL] [Abstract][Full Text] [Related]
59. No evidence of HTLV-I infection in patients with mycosis fungoides and Sezary syndrome.
Pawlaczyk M; Filas V; Sobieska M; Gozdzicka-Józefiak A; Wiktorowicz K; Breborowicz J
Neoplasma; 2005; 52(1):52-5. PubMed ID: 15739027
[TBL] [Abstract][Full Text] [Related]
60. CCR4 is expressed on infiltrating cells in lesional skin of early mycosis fungoides and atopic dermatitis.
Sugaya M; Morimura S; Suga H; Kawaguchi M; Miyagaki T; Ohmatsu H; Fujita H; Sato S
J Dermatol; 2015 Jun; 42(6):613-5. PubMed ID: 25809616
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
